Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Annexon Inc (NQ: ANNX ) 5.825 +0.195 (+3.46%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,129,566 Open 5.650 Bid (Size) 5.000 (4) Ask (Size) 5.890 (20) Prev. Close 5.630 Today's Range 5.460 - 5.860 52wk Range 1.570 - 8.400 Shares Outstanding 47,722,995 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) July 16, 2024 From Annexon Biosciences Via GlobeNewswire Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday July 12, 2024 Via Benzinga Performance YTD +20.35% +20.35% 1 Month +22.12% +22.12% 3 Month +28.16% +28.16% 6 Month +30.90% +30.90% 1 Year +77.59% +77.59% More News Read More Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting July 11, 2024 From Annexon Biosciences Via GlobeNewswire ANNX Stock Earnings: Annexon Beats EPS for Q1 2024 May 13, 2024 Via InvestorPlace 10 Health Care Stocks Whale Activity In Today's Session July 10, 2024 Via Benzinga Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting June 25, 2024 From Annexon Biosciences Via GlobeNewswire 7 Top Stocks Under $10: June 2024 Edition June 24, 2024 Via InvestorPlace Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting June 18, 2024 From Annexon Biosciences Via GlobeNewswire Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) June 17, 2024 From Annexon Biosciences Via GlobeNewswire Annexon Announces Pricing of $125 Million Underwritten Public Offering June 05, 2024 From Annexon Biosciences Via GlobeNewswire DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket June 05, 2024 Via Benzinga Annexon Announces Proposed Public Offering of Common Stock June 04, 2024 From Annexon Biosciences Via GlobeNewswire Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings June 04, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 04, 2024 Via Benzinga Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study June 04, 2024 Via Benzinga Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results June 04, 2024 Via Benzinga Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 04, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 04, 2024 Via InvestorPlace Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome June 04, 2024 From Annexon Biosciences Via GlobeNewswire Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket June 04, 2024 Via Benzinga Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data June 03, 2024 From Annexon Biosciences Via GlobeNewswire Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) May 16, 2024 From Annexon Biosciences Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.